CENP-B specific anti-centromere autoantibodies heralding small-cell lung cancer. A case study and review of the literature

Lung Cancer

Volumn 60, Issue 2, 2008, Pages 302-306

  Briasoulis, Evangelos ^a,b   Kamposioras, Konstantinos ^b   Tzovaras, Vasilis ^b   Pafitanis, George ^a   Kostoula, Angeliki ^b   Mavridis, Anestis ^a,b   Pavlidis, Nicholas ^a,b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Autoantibodies; Carcinoma; Centromere protein B; Small cell lung; Tumor markers

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CENTROMERE PROTEIN B; CISPLATIN; ETOPOSIDE; TUMOR MARKER;

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER REGRESSION; CASE REPORT; CHEMICAL ANALYSIS; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FIBEROPTIC BRONCHOSCOPY; HUMAN; IMMUNOFLUORESCENCE; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; SUPERIOR CAVA VEIN SYNDROME; THORAX RADIOGRAPHY; TREATMENT RESPONSE; TUMOR RECURRENCE;

ANTIBODIES, ANTINUCLEAR; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AUTOANTIGENS; CARCINOMA, SMALL CELL; CENTROMERE PROTEIN B; COMBINED MODALITY THERAPY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOBLOTTING; LUNG NEOPLASMS; MIDDLE AGED; RADIOTHERAPY; SMOKING; SUPERIOR VENA CAVA SYNDROME;

EID: 42949127149     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.09.014     Document Type: Article

References (28)

1. Margolis M.L., Hyzy J.B., Schenken L.L., and Schepart B.S. Serum tumor markers in non-small cell lung cancer. A comparative analysis. Cancer 73 3 (1994) 605-609
2. Hansen H.H., and Hansen M. Tumor markers in small cell lung cancer. Eur J Cancer Clin Oncol 23 11 (1987) 1585-1587
3. Fernandez-Madrid F., VandeVord P.J., Yang X., Karvonen R.L., Simpson P.M., Kraut M.J., et al. Antinuclear antibodies as potential markers of lung cancer. Clin Cancer Res 5 6 (1999) 1393-1400
4. Abu-Shakra M., Buskila D., Ehrenfeld M., Conrad K., and Shoenfeld Y. Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Ann Rheum Dis 60 5 (2001) 433-441
5. McCarty G.A. Autoimmunity and malignancy. Med Clin North Am 69 3 (1985) 599-615
6. Solans-Laque R., Perez-Bocanegra C., Salud-Salvia A., Fonollosa-Pla V., Rodrigo M.J., Armadans L., et al. Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromes. Lupus 13 3 (2004) 159-164
7. Gogas H., Ioannovich J., Dafni U., Stavropoulou-Giokas C., Frangia K., Tsoutsos D., et al. Prognostic significance of autoimmunity during treatment of melanoma with interferon. N Engl J Med 354 7 (2006) 709-718
8. Inuzuka T. Autoantibodies in paraneoplastic neurological syndrome. Am J Med Sci 319 4 (2000) 217-226
9. Kiers L., Altermatt H.J., and Lennon V.A. Paraneoplastic anti-neuronal nuclear IgG autoantibodies (type I) localize antigen in small cell lung carcinoma. Mayo Clin Proc 66 12 (1991) 1209-1216
10. Chapman C., Murray A., Chakrabarti J., Thorpe A., Woolston C., Sahin U., et al. Autoantibodies in breast cancer: their use as an aid to early diagnosis. Ann Oncol 18 5 (2007) 868-873
11. Fernandez M.F., Karvonen R.L., Ensley J., Kraut M., Granda J.L., Alansari H., et al. Spectra of antinuclear antibodies in patients with squamous cell carcinoma of the lung and of the head and neck. Cancer Detect Prev 29 1 (2005) 59-65
12. Imran A., Neelam F., and Tariq M. Incidence of circulating antinuclear antibodies in cancer patients. Indian J Med Sci 57 3 (2003) 113-116
13. Takeuchi Y., Yoshikawa M., Tsukamoto N., Shiroi A., Hoshida Y., Enomoto Y., et al. Cronkhite-Canada syndrome with colon cancer, portal thrombosis, high titer of antinuclear antibodies, and membranous glomerulonephritis. J Gastroenterol 38 8 (2003) 791-795
14. Ando S., Yang H., Nozaki N., Okazaki T., and Yoda K. CENP-A, -B, and -C chromatin complex that contains the I-type alpha-satellite array constitutes the prekinetochore in HeLa cells. Mol Cell Biol 22 7 (2002) 2229-2241
15. Moroi Y., Peebles C., Fritzler M.J., Steigerwald J., and Tan E.M. Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci USA 77 3 (1980) 1627-1631
16. Miyawaki S., Asanuma H., Nishiyama S., and Yoshinaga Y. Clinical and serological heterogeneity in patients with anticentromere antibodies. J Rheumatol 32 8 (2005) 1488-1494
17. Tomonaga T., Matsushita K., Ishibashi M., Nezu M., Shimada H., Ochiai T., et al. Centromere protein H is up-regulated in primary human colorectal cancer and its overexpression induces aneuploidy. Cancer Res 65 11 (2005) 4683-4689
18. Erlanson M., Casiano C.A., Tan E.M., Lindh J., Roos G., and Landberg G. Immunohistochemical analysis of the proliferation associated nuclear antigen CENP-F in non-Hodgkin's lymphoma. Mod Pathol 12 1 (1999) 69-74
19. Bencimon C., Salles G., Moreira A., Guyomard S., Coiffier B., Bienvenu J., et al. Prevalence of anticentromere F protein autoantibodies in 347 patients with non-Hodgkin's lymphoma. Ann NY Acad Sci 1050 (2005) 319-326
20. Tanaka Y., Tachiwana H., Yoda K., Masumoto H., Okazaki T., Kurumizaka H., et al. Human centromere protein B induces translational positioning of nucleosomes on alpha-satellite sequences. J Biol Chem 280 50 (2005) 41609-41618
21. Yoda K., Ando S., Okuda A., Kikuchi A., and Okazaki T. In vitro assembly of the CENP-B/alpha-satellite DNA/core histone complex: CENP-B causes nucleosome positioning. Genes Cells 3 8 (1998) 533-548
22. Zuber M., Gotzen R., and Filler I. Clinical correlation of anticentromere antibodies. Clin Rheumatol 13 3 (1994) 427-432
23. Casiano C.A., Humbel R.L., Peebles C., Covini G., and Tan E.M. Autoimmunity to the cell cycle-dependent centromere protein p330d/CENP-F in disorders associated with cell proliferation. J Autoimmun 8 4 (1995) 575-586
24. Rattner J.B., Rees J., Whitehead C.M., Casiano C.A., Tan E.M., Humbel R.L., et al. High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F. Clin Invest Med 20 5 (1997) 308-319
25. Higuchi M., Horiuchi T., Ishibashi N., Yoshizawa S., Niho Y., and Nagasawa K. Anticentromere antibody as a risk factor for cancer in patients with systemic sclerosis. Clin Rheumatol 19 2 (2000) 123-126
26. Bonaci-Nikolic B., Andrejevic S., Bukilica M., Urosevic I., and Nikolic M. Autoantibodies to mitotic apparatus: association with other autoantibodies and their clinical significance. J Clin Immunol 26 5 (2006) 438-446
27. Zhang J.Y., Zhu W., Imai H., Kiyosawa K., Chan E.K., and Tan E.M. De-novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma. Clin Exp Immunol 125 1 (2001) 3-9
28. Atalay C., Atalay G., Yilmaz K.B., and Altinok M. The role of anti-CENP-B and anti-SS-B antibodies in breast cancer. Neoplasma 52 1 (2005) 32-35